These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32167945)

  • 1. Small molecule therapeutics to treat the β-globinopathies.
    Yu L; Myers G; Engel JD
    Curr Opin Hematol; 2020 May; 27(3):129-140. PubMed ID: 32167945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. When basic science reaches into rational therapeutic design: from historical to novel leads for the treatment of β-globinopathies.
    Andrieu-Soler C; Soler E
    Curr Opin Hematol; 2020 May; 27(3):141-148. PubMed ID: 32167946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural regulatory mutations elevate the fetal globin gene via disruption of BCL11A or ZBTB7A binding.
    Martyn GE; Wienert B; Yang L; Shah M; Norton LJ; Burdach J; Kurita R; Nakamura Y; Pearson RCM; Funnell APW; Quinlan KGR; Crossley M
    Nat Genet; 2018 Apr; 50(4):498-503. PubMed ID: 29610478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A natural regulatory mutation in the proximal promoter elevates fetal
    Martyn GE; Wienert B; Kurita R; Nakamura Y; Quinlan KGR; Crossley M
    Blood; 2019 Feb; 133(8):852-856. PubMed ID: 30617196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A genome-editing strategy to treat β-hemoglobinopathies that recapitulates a mutation associated with a benign genetic condition.
    Traxler EA; Yao Y; Wang YD; Woodard KJ; Kurita R; Nakamura Y; Hughes JR; Hardison RC; Blobel GA; Li C; Weiss MJ
    Nat Med; 2016 Sep; 22(9):987-90. PubMed ID: 27525524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of novel HPFH-like mutations by CRISPR base editing that elevate the expression of fetal hemoglobin.
    Ravi NS; Wienert B; Wyman SK; Bell HW; George A; Mahalingam G; Vu JT; Prasad K; Bandlamudi BP; Devaraju N; Rajendiran V; Syedbasha N; Pai AA; Nakamura Y; Kurita R; Narayanasamy M; Balasubramanian P; Thangavel S; Marepally S; Velayudhan SR; Srivastava A; DeWitt MA; Crossley M; Corn JE; Mohankumar KM
    Elife; 2022 Feb; 11():. PubMed ID: 35147495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Featured Article: Modulation of fetal hemoglobin in hereditary persistence of fetal hemoglobin deletion type-2, compared to Sicilian δβ-thalassemia, by BCL11A and SOX6-targeting microRNAs.
    Fornari TA; Lanaro C; Albuquerque DM; Ferreira R; Costa FF
    Exp Biol Med (Maywood); 2017 Feb; 242(3):267-274. PubMed ID: 27591578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Original Research: Generation of non-deletional hereditary persistence of fetal hemoglobin β-globin locus yeast artificial chromosome transgenic mouse models: -175 Black HPFH and -195 Brazilian HPFH.
    Braghini CA; Costa FC; Fedosyuk H; Neades RY; Novikova LV; Parker MP; Winefield RD; Peterson KR
    Exp Biol Med (Maywood); 2016 Apr; 241(7):697-705. PubMed ID: 26946532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A; Troia A; Calzolari R; Scazzone C; Rigano P; Martorana A; Sacco M; Maggio A; Di Marzo R
    Hemoglobin; 2015; 39(4):225-9. PubMed ID: 26016899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of human gamma-globin are expressed in adult mice carrying a transgene of the Brazilian type of hereditary persistence of fetal hemoglobin ((A)gamma -195).
    da Cunha AF; Brugnerotto AF; Corat MA; Devlin EE; Gimenes AP; de Melo MB; Passos LA; Bodine D; Saad ST; Costa FF
    Hemoglobin; 2009; 33(6):439-47. PubMed ID: 19958189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
    Krivega I; Byrnes C; de Vasconcellos JF; Lee YT; Kaushal M; Dean A; Miller JL
    Blood; 2015 Jul; 126(5):665-72. PubMed ID: 25979948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
    Cui S; Engel JD
    Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpreting elevated fetal hemoglobin in pathology and health at the basic laboratory level: new and known γ- gene mutations associated with hereditary persistence of fetal hemoglobin.
    Amato A; Cappabianca MP; Perri M; Zaghis I; Grisanti P; Ponzini D; Di Biagio P
    Int J Lab Hematol; 2014 Feb; 36(1):13-9. PubMed ID: 23621512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of the LSD1 inhibitor ORY-3001 increases fetal hemoglobin in sickle cell mice and baboons.
    Rivers A; Vaitkus K; Jagadeeswaran R; Ruiz MA; Ibanez V; Ciceri F; Cavalcanti F; Molokie RE; Saunthararajah Y; Engel JD; DeSimone J; Lavelle D
    Exp Hematol; 2018 Nov; 67():60-64.e2. PubMed ID: 30125603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Regulation of γ-globin gene expression and its clinical applications].
    Ju JY; Zhao Q
    Yi Chuan; 2018 Jun; 40(6):429-444. PubMed ID: 29959116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel therapeutic candidates, identified by molecular modeling, induce γ-globin gene expression in vivo.
    Boosalis MS; Castaneda SA; Trudel M; Mabaera R; White GL; Lowrey CH; Emery DW; Mpollo MS; Shen L; Wargin WA; Bohacek R; Faller DV; Perrine SP
    Blood Cells Mol Dis; 2011 Aug; 47(2):107-16. PubMed ID: 21641240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Precision Editing as a Therapeutic Approach for β-Hemoglobinopathies.
    Paschoudi K; Yannaki E; Psatha N
    Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Editing a γ-globin repressor binding site restores fetal hemoglobin synthesis and corrects the sickle cell disease phenotype.
    Weber L; Frati G; Felix T; Hardouin G; Casini A; Wollenschlaeger C; Meneghini V; Masson C; De Cian A; Chalumeau A; Mavilio F; Amendola M; Andre-Schmutz I; Cereseto A; El Nemer W; Concordet JP; Giovannangeli C; Cavazzana M; Miccio A
    Sci Adv; 2020 Feb; 6(7):. PubMed ID: 32917636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lysine-specific demethylase 1 is a therapeutic target for fetal hemoglobin induction.
    Shi L; Cui S; Engel JD; Tanabe O
    Nat Med; 2013 Mar; 19(3):291-4. PubMed ID: 23416702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benserazide racemate and enantiomers induce fetal globin gene expression in vivo: Studies to guide clinical development for beta thalassemia and sickle cell disease.
    Pace BS; Perrine S; Li B; Makala L; Xu H; Takezaki M; Wolf RF; Wang A; Xu X; Huang J; Alimardanov A; Tawa GJ; Sangerman J; Faller A; Zheng W; Toney L; Haugabook SJ
    Blood Cells Mol Dis; 2021 Jul; 89():102561. PubMed ID: 33744514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.